The ANP knockout mouse is reported to exhibit pregnancy-associated hypertension, proteinuria and impaired placental trophoblast invasion and spiral artery remodeling, key features of pre-eclampsia (PE). We hypothesized that these mice may provide a relevant model of human PE with associated fetal growth restriction (FGR). Here, we investigated pregnancies of ANP wild type (ANP þ/þ ), heterozygous (ANP þ/-) and knockout (ANP À/-) mice. Maternal blood pressure did not differ between genotypes (E12.5, E17.5), and fetal weight (E18.5) was unaffected. Placental weight was greater in ANP À/À versus ANP þ/þ mice. Therefore, in our hands, the ANP model does not express phenotypic features of PE with FGR.
Introduction
Pre-eclampsia (PE), the leading cause of maternal and perinatal morbidity and mortality worldwide, affects 3e5% of all pregnancies [1] . PE is characterized by the onset of hypertension and proteinuria, from 20 weeks gestation [2] , and is associated with placental dysfunction and widespread maternal vascular endothelium activation [3, 4] leading to the pathophysiology of multi-system organ dysfunction. To date, there are no treatments for PE, the only effective intervention being premature delivery of the baby [5e7] .
The development of clinically relevant mouse models of human pregnancy complications such as PE and fetal growth restriction (FGR) is essential for furthering our understanding of these conditions and for testing potential therapies [8] . Despite the fact that, in humans, PE is the leading cause of FGR [9] , to our knowledge there remain no reports of a genetically modified mouse that demonstrates PE with FGR.
Atrial natriuretic peptide (ANP) plays a key role in blood pressure regulation and sodium homeostasis [10, 11] . Previous studies have reported that adult male ANP knockout (ANP counterparts, although fetal weight was not reported [13] . Here, we tested the hypothesis that ANP À/À mice exhibit FGR in addition to phenotypic features of PE.
Methods

Animals
Animal care and experimental procedures were performed in accordance with the U.K. Animals (Scientific Procedures) Act 1986. ANP mice (strain: B6.129P2-Nppa tm1Unc /J), were obtained from Jackson Laboratories and the colony was maintained as heterozygous breeding pairs. Experimental animals of each genotype (ANP
) were mated in genotype-matched pairs; the presence of a copulation plug was designated as embryonic day (E) 0.5 of pregnancy. Animals had food (Beekay Rat and Mouse Diet; Bantin & Kingman, UK) and water ad libitum, and were maintained À mice did not demonstrate proteinuria at E18.5. Lines represent median, n ¼ 7e8. 
on a 12:12-h light-dark cycle at 21e23 C. DNA was extracted from ear clips (offspring, at weaning) or fetal tail tips for genotype determination (primers and PCR conditions available on request). Blood pressure was measured using a previously validated tailcuff method (LE5001; Pan Lab, Spain, [14] ). Systolic blood pressure (SBP) measurements were made in non-pregnant mice (2e4 days pre-mating) and subsequently in pregnant mice (E12.5 and E17.5). At E18.5, fetuses and placentas were rapidly harvested and wet weights recorded. Fetal weight centile charts were constructed as previously described [15] .
Urine albumin and creatinine concentration
Maternal urine was collected at E18.5 by spontaneous voiding and aliquoted and stored at À20 C. Urinary albumin (mouse ELISA; AssayPro, St Charles, MO), and creatinine (Cayman Chemical Company, Ann Arbour, MI) concentration was measured and the albumin/creatinine ratio calculated.
Statistical analysis
Data are presented as mean ± SD or dot plots of litter means with median. Statistical analysis was by two-way ANOVA or Kruskal-Wallis test as appropriate. P < 0.05 was deemed significant.
Results and discussion
In contrast to previous reports [13, 16] , neither ANP À/À , nor ANP þ/À dams demonstrated a hypertensive phenotype either before or during pregnancy (Fig 1A) . Indeed, the SBP values for all dams obtained in the present study were comparable to that of our C57Bl/6J mice, the ANP model's background strain (E17.5 SBP of 116.5 ± 3.9 mmHg, n ¼ 6). This discrepancy between observations from different laboratories may be due to methodological differences e.g. use of radiotelemetry compared with tail cuff technique employed here. However, it is important to note that the first paper describing the phenotype of ANP À/À animals, which used a similar tail cuff technique to our own, showed only relatively minor differences in SBP unless animals were challenged with a high-salt diet [12] . Furthermore, it is unlikely a deficiency in the tail cuff technique used, as our contemporaneous measurements from pregnant eNOS À/À mice (an established model of hypertension,
[17e19]) demonstrated significantly elevated SBP in this model (E17.5, 136.0 ± 8.7 mmHg, n ¼ 6). Concomitant with a lack of raised SBP, there was no evidence of proteinuria in ANP À/À compared with ANP þ/þ dams (Fig 1B) . We (from ANP À/À homozygous matings) and ANP þ/þ mice (Fig. 2B) and there was no significant difference in the number of fetuses falling below the 5th percentile (defined as FGR, [15] ), strengthening the assertion that ANP deletion does not cause FGR. Indeed, there was a non-significant rightward shift of the growth curve of ANP À/À fetuses, which may be related to oedema, which was apparent in a number of fetuses (data not shown). Similarly, placental wet weight was significantly greater in ANP À/À compared to ANP þ/þ fetuses ( Fig. 2A , P < 0.01). In summary, we find that deletion of the ANP gene in mice is associated with increased placental weight and a failure to thrive in the neonatal period, but not with phenotypic features of PE or FGR. These data reinforce the need to identify robust animal models of pregnancy complications in which to test candidate therapeutics, and the importance of fully characterizing animal models in independent laboratories before they can be established for use in obstetric research.
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